Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Teladoc Health Inc
SWB:4LL
Teladoc Health Inc
SWB:4LL
Price:
8.006
EUR
-2.34%
Market Closed
Market Cap:
€9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Teladoc Health Inc
SWB:4LL
|
US |
|
Iberdrola SA
OTC:IBDRY
|
ES |
|
M
|
Medtronic PLC
XMUN:2M6
|
IE |
|
OEL (Holdings) Ltd
SGX:584
|
SG |
|
B
|
Bank of New York Mellon Corp
DUS:BN9
|
US |
|
M
|
Metagenomi Therapeutics Inc
NASDAQ:MGX
|
US |
|
E
|
Expeditors International of Washington Inc
F:EW1
|
US |
Wall St Price Targets
4LL Price Forecast
Based on 21 analysts
Based on 21 analysts
-18% Downside
from
€8.006
today
Teladoc Health Inc (4LL)’s 12-month stock price forecast through July 2027 has a consensus target of €6.592, implying 18% downside. The forecast is based on price targets from 21 Wall Street analysts.
4LL Analyst Rating
No ratings yet
No ratings yet
Teladoc Health Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4LL's stock price target?
Price Target
6.592
EUR
6.592
EUR
According to Wall Street analysts, the average 1-year price target for 4LL is 6.592 EUR with a low forecast of 4.787 EUR and a high forecast of 9.5 EUR.
What is the Revenue forecast for Teladoc Health Inc?
Projected CAGR
0%
0%
Over the last 11 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 5 years is 0%.
What is the Gross Profit forecast for Teladoc Health Inc?
Projected CAGR
-1%
-1%
Over the last 11 years, the compound annual growth rate for Gross Profit has been 43%. The projected CAGR for the next 5 years is -1%.